During the past decade, Joslin Diabetes Center conducted 86 clinical trials. In the 10-year time frame, 86 clinical trials started and 41 clinical trials were completed, i.e. on average, 47.7% percent of trials that started reached the finish line to date. In the past 5 years, 37 clinical trials started and 19 clinical trials were completed. i.e. 51.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Joslin Diabetes Center" #1 sponsor was "Joslin Diabetes Center" with 60 trials, followed by "Jaeb Center for Health Research" with 24 trials sponsored, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 15 trials sponsored, "DexCom, Inc." with 6 trials sponsored and "Eli Lilly and Company" with 6 trials sponsored. Other sponsors include 48 different institutions and companies that sponsored additional 42 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Joslin Diabetes Center" #1 collaborator was "National Eye Institute (NEI)" with 19 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 19 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 15 trials as a collaborator, "Joslin Diabetes Center" with 9 trials as a collaborator and "National Institutes of Health (NIH)" with 9 trials as a collaborator. Other collaborators include 174 different institutions and companies that were collaborators in the rest 106 trials.

According to Clinical.Site data, the most researched conditions in "Joslin Diabetes Center" are "Type 1 Diabetes" (20 trials), "Type 1 Diabetes Mellitus" (16 trials), "Diabetes Mellitus, Type 1" (14 trials), "Diabetic Macular Edema" (14 trials) and "Type 2 Diabetes" (14 trials). Many other conditions were trialed in "Joslin Diabetes Center" in a lesser frequency.

Most popular intervention types in "Joslin Diabetes Center" are "Drug" (68 trials), "Other" (31 trials), "Device" (28 trials), "Behavioral" (27 trials) and "Procedure" (16 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "Salsalate" (3 trials), "Allopurinol" (2 trials), "Continuous Glucose Monitor" (2 trials) and "Dapagliflozin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Joslin Diabetes Center" are 161 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Joslin Diabetes Center". undefined are not yet recruiting, 20 are recruiting, 9 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 116 completed trials in Joslin Diabetes Center, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Joslin Diabetes Center, 8 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 58 trials that are defined as “Not Applicable".

Joslin Diabetes Center has several departments that took part in Clinical trials: "Joslin Diabetes Center - Adults" - 2 trials, "Beetham Eye Institute, Joslin Diabetes Center" - 2 trials, "Joslin Diabetes Center - Children" - 2 trials